Improved diagnostics and prognostics of lung cancer and metastases to the lungs
41 – 50 of 75
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Association Analysis of Driver Gene-Related Genetic Variants Identified Novel Lung Cancer Susceptibility Loci with 20,871 Lung Cancer Cases and 15,971 Controls
2020) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29(7). p.1423-1429(
- Contribution to journal › Article
-
Mark
Typical and atypical carcinoid tumors of the lung : a clinicopathological correlation of 783 cases with emphasis on histological features
(
- Contribution to journal › Article
-
Mark
Radiologisk och histologisk bild för en ökad förståelse vid covid-19
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Diagnostic value of insulinoma-associated protein 1 (INSM1) and comparison with established neuroendocrine markers in pulmonary cancers
(
- Contribution to journal › Article
-
Mark
Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non-small cell lung cancer
(
- Contribution to journal › Article
- 2019
-
Mark
Genetic interaction analysis among oncogenesis-related genes revealed novel genes and networks in lung cancer development
(
- Contribution to journal › Article
-
Mark
A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Mucin staining is of limited value in addition to basic immunohistochemical analyses in the diagnostics of non-small cell lung cancer
(
- Contribution to journal › Article
-
Mark
Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11
(
- Contribution to journal › Article